The Expression of Recombinant Proteins in Crop Plants
Antibodies, produced in and extracted from immunized animals, have enjoyed a wide range of uses as vaccines and therapeutic agents. Because of their high specificity and ability to bind tightly to antigens there are almost limitless potential applications for their exploitation, and therapeutic antibodies alone are worth $1000m a year. Two factors currently limit their use: concern over the use of laboratory animals, and the small scale of production possible by this route. However, it is now possible to produce and extract fully functional recombinant antibodies from plants, and new applications may be envisaged in human healthcare products and industrial scale purification processes. The plant phenotype may also be modified to produce antibodies bringing about resistance to plant pests and diseases, modification of metabolic pathways, or bioremediation of pollutants or polluted land.